Evidence map›Paper›PMID 42557443›Full record

ArticleNature neuroscience2026

Norepinephrine and dopamine sensor crosstalk depends on local innervation density.

Ricardo C López, Natalie Noble, Özge D Özçete, Leonardo Silenzi, Xintong Cai, Gillian E Handy, Jonathan W Andersen, Tommaso Patriarchi, Yulong Li, Pascal S Kaeser

Abstract read
In one paragraph

Article in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The Synaptic Vesicle Priming Protein Munc13 Mediates Evoked Somatodendritic Dopamine Release.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ricardo C LópezDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1136-9511
Natalie Noble *Department of Neurobiology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8127-9741
Özge D Özçete *Department of Neurobiology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0717-7936
Leonardo SilenziDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Xintong CaiDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Gillian E HandyDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Jonathan W AndersenDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Tommaso PatriarchiInstitute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0001-9351-3734
Yulong LiState Key Laboratory of Membrane Biology, Peking University School of Life Sciences, Beijing, China.ORCID http://orcid.org/0000-0002-9166-9919
Pascal S KaeserDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA. kaeser@hms.harvard.edu.ORCID http://orcid.org/0000-0002-1558-1958

Funding

Molecular Dissection of Active Zone Functions in Neurotransmitter ReleaseR01NS083898 · NINDS · HARVARD MEDICAL SCHOOL · PI Pascal Simon Kaeser · 2014 to 2026
$5.9M
Architecture and Function of Striatal Dopamine Signaling MachineryR01NS103484 · NINDS · HARVARD MEDICAL SCHOOL · PI Pascal Simon Kaeser · 2017 to 2026
$4.7M
Mechanisms for somatodendritic dopamine release in the midbrainR01DA056109 · NIDA · HARVARD MEDICAL SCHOOL · PI Pascal Simon Kaeser, John T Williams · 2023 to 2026
$2.3M
Roles for dopamine signaling modes in striatal circuit modulation and behaviorR01DA058777 · NIDA · HARVARD MEDICAL SCHOOL · PI Pascal Simon Kaeser, Naoshige Uchida · 2024 to 2026
$2.0M
Department of Neurobiology, Harvard Medical School Quan FellowshipHarvard Medical School NAHuman Frontier Science Program (HFSP) LT0004/2022National Science Foundation (NSF) DGE2140743NIDA NIH HHS R01 DA056109NIDA NIH HHS R01 DA058777NINDS NIH HHS R01 NS083898NINDS NIH HHS R01 NS103484U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS083898U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS103484U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA056109U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA058777
6 · The paper itself

Abstract

G-protein-coupled receptor-based fluorescent sensors are widely used to correlate neuromodulatory signaling with brain function. Although experiments in transfected cells often reveal selectivity for individual neurotransmitters, sensor specificity in the brain frequently remains uncertain. Using imaging in mouse brains, we find that norepinephrine and dopamine cross-activate the respective sensors. Non-specific activation occurred when innervation of the cross-reacting transmitter was high, and silencing of specific innervation was indispensable for interpreting sensor fluorescence.

Indexed as

BrainDopamineNeuronsNorepinephrineReceptor Cross-TalkAnimalsMiceMice, TransgenicReceptors, G-Protein-CoupledDopamineNorepinephrineReceptors, G-Protein-Coupled

Identifiers

PMID42557443
PMCPMC13533832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.